March 20, 2026

Healthy Lifestyle Lowers Cardiometabolic Risk in Hypertension

Sustained and improved behaviors following diagnosis tied to lower cardiometabolic risk, highlighting an underused opportunity in care

Conexiant

March 19, 2026

Wegovy HD Secures FDA Approval

Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.

Conexiant

March 19, 2026

PREVENT Equations Show How Age, Risk Factors Shape CVD Risk

Systematic analysis demonstrates how kidney disease, diabetes, and other factors accelerate 10-year cardiovascular risk, helping guide clinician–patient prevention discussions.

Conexiant

March 18, 2026

Premature Menopause Tied to Higher Lifetime CHD Risk

Lifetime risk estimates evaluated by menopause timing.

Conexiant

March 18, 2026

Medical Oddities: Friends, Family… and Faster Aging?

From gut gas trackers to bat vaccines, relationships and aging, GLP-1 hair shifts, and bug-based delivery—medicine keeps getting creative.

Conexiant

March 18, 2026

Side Effects: The Nose Knows

A nasal swab may detect Alzheimer's before symptoms appear — and the immune system is already loud about it

Conexiant

March 18, 2026

Exercise in a Pill Is Now in Human Trials

Atrogi's ATR-258 just dosed its first subjects — and the muscle data it's hunting could reframe how we treat weight loss.

Conexiant

March 18, 2026

Expanding CGM Access for Medicare Patients

“Insurance coverage of CGM is frequently identified in the literature as a barrier to CGM access."

Conexiant

March 17, 2026

saRNA Injection Targets Cardiac Injury

Preclinical study shows saRNA therapy improved cardiac function and reduced infarct size after myocardial infarction

The Medicine Maker

March 17, 2026

Updated Guidelines for Reducing Heart Disease and Stroke Risks

Preventive cardiologist Heather Johnson, M.D., was part of the writing committee for a new, comprehensive tool for assessing and treating these health risks.

Baptist Health South Florida